Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in OCGN — Ocugen, Inc.

CIK 886982 NEW YORK, NY
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,561,967
-$478,637 QoQ
Shares Held
1,020,894
-9.4% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 147 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. OCGN ranks #236 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in OCGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,561,967 1,020,894
2026-03-31 $2,040,604 1,127,406
2025-12-31 $3,108,341 2,302,475
2025-09-30 $159,266 97,710
2025-06-30 $860,440 887,052
2025-03-31 $424,079 600,679
2024-12-31 $664,806 825,847
2024-09-30 $925,274 932,737
2024-06-30 $1,177,132 759,440
2024-03-31 $4,276,505 2,607,625
2023-06-30 $38,373 70,669
2023-03-31 $601,279 704,900
2022-12-31 $2,008,779 1,545,215
2022-09-30 $3,549,177 1,993,920
2022-06-30 $3,581,296 1,577,664
2022-03-31 $3,237,061 980,928
2021-12-31 $1,003,829 220,622
2021-09-30 $1,618,364 225,399
2021-06-30 $1,867,375 232,550
2021-03-31 $2,217,396 326,568
2020-12-31 $20,602 11,258